Income Statement Waverley Pharma Inc.

Stocks

WAVE

CA94357L1058

Biotechnology & Medical Research

Market Closed - Toronto S.E. Other stock markets 13:02:53 2026-06-23 EDT			5-day change	1st Jan Change
0.0250 ^CAD	-.--%		-.--%	+25.00%

05-22	Waverley Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
04-30	Waverley Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

1a57.o4lTW9x3Ibxb9D4XSr1aUh7l9qhI4bPOmmpk6IH5h60.28EFNZITVc8fs3QuPsQ0CFbXvcI-kuL70Vo02tCA7Ovq8QMOhSZo1RiAbw

Published financial data: WAVERLEY PHARMA INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	1.75M	1.25M	412K	475K	1.35M
Total Revenues	1.75M	1.25M	412K	475K	1.35M
Cost of Goods Sold, Total	1.53M	963K	332K	261K	836K
Gross Profit	223K	284K	79.8K	214K	514K
Selling General & Admin Expenses, Total	956K	1.14M	1.13M	652K	850K
R&D Expenses	53.79K	81.66K	235K	424K	13.46K
Other Operating Expenses, Total	1.01M	1.22M	1.36M	1.08M	863K
Operating Income	-787K	-936K	-1.28M	-862K	-349K
Interest Expense, Total	-3.04K	-16.64K	-76.65K	-163K	-179K
Interest And Investment Income	-	-	-	1.08K	2.31K
Net Interest Expenses	-3.04K	-16.64K	-76.65K	-161K	-177K
Currency Exchange Gains (Loss)	-48.62K	-9.28K	-578	-41.1K	29.42K
Other Non Operating Income (Expenses)	41.98K	298K	78.64K	117K	-769
EBT, Excl. Unusual Items	-797K	-664K	-1.28M	-947K	-498K
Asset Writedown	-	-	-943K	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-797K	-664K	-2.22M	-947K	-498K
Income Tax Expense	-	-	-	-	1.63K
Earnings From Continuing Operations	-797K	-664K	-2.22M	-947K	-499K
Net Income to Company	-797K	-664K	-2.22M	-947K	-499K
Net Income - (IS)	-797K	-664K	-2.22M	-947K	-499K
Net Income to Common Incl Extra Items	-797K	-664K	-2.22M	-947K	-499K
Net Income to Common Excl. Extra Items	-797K	-664K	-2.22M	-947K	-499K
Per Share Items
Net EPS - Basic	-0.01	-0.01	-0.04	-0.02	-0.01
Basic EPS - Continuing Operations	-0.01	-0.01	-0.04	-0.02	-0.01
Basic Weighted Average Shares Outstanding	54M	54M	54M	54M	54M
Net EPS - Diluted	-0.01	-0.01	-0.04	-0.02	-0.01
Diluted EPS - Continuing Operations	-0.01	-0.01	-0.04	-0.02	-0.01
Diluted Weighted Average Shares Outstanding	54M	54M	54M	54M	54M
Normalized Basic EPS	-0.01	-0.01	-0.01	-0.01	-0.01
Normalized Diluted EPS	-0.01	-0.01	-0.01	-0.01	-0.01
Supplemental Items
EBITDA	-759K	-828K	-961K	-845K	-291K
EBITA	-759K	-828K	-961K	-846K	-295K
EBIT	-787K	-936K	-1.28M	-862K	-349K
Effective Tax Rate - (Ratio)	-	-	-	-	-0.33
Total Current Taxes	-	-	-	-	1.63K
Normalized Net Income	-498K	-415K	-801K	-592K	-311K
Interest on Long-Term Debt	-	-	-	4.09K	17.78K
Supplemental Operating Expense Items
General and Administrative Expenses	-	-	-	-	-
Research And Development Expense From Footnotes	53.79K	81.66K	235K	424K	13.46K
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., G&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., SG&A Exp. (Total)	261	-	-	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	261	-	-	-	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	158K	134K	53.02K	236K	44.95K
Total Cash And Short Term Investments	158K	134K	53.02K	236K	44.95K
Accounts Receivable, Total	424K	191K	135K	53.06K	32.66K
Other Receivables	278K	2.4K	2.88K	156K	812
Total Receivables	702K	193K	138K	209K	33.47K
Inventory	330K	61.52K	633	261K	306K
Prepaid Expenses	256K	244K	225K	23.62K	36.13K
Total Current Assets	1.45M	633K	417K	730K	421K
Gross Property Plant And Equipment	-	-	-	272K	259K
Accumulated Depreciation	-	-	-	-8.37K	-36.1K
Net Property Plant And Equipment	-	-	-	263K	223K
Goodwill	-	-	-	224K	213K
Other Intangibles, Total	1.76M	1.68M	265K	398K	326K
Other Long-Term Assets, Total	480K	375K	271K	431K	62.29K
Total Assets	3.68M	2.69M	952K	2.05M	1.24M
Liabilities
Accounts Payable, Total	1.03M	680K	450K	963K	369K
Accrued Expenses, Total	602K	175K	-	-	789
Short-term Borrowings	222K	662K	1.6M	2.81M	3.22M
Current Portion of Long-Term Debt	40K	40K	-	-	-
Current Portion of Leases	-	-	-	37.12K	45.53K
Current Income Taxes Payable	-	-	-	-	794
Other Current Liabilities	-	39.85K	36.8K	47.71K	-
Total Current Liabilities	1.89M	1.6M	2.09M	3.86M	3.64M
Long-Term Debt	-	-	-	-	-
Long-Term Leases	-	-	-	219K	179K
Other Non Current Liabilities	-	-	-	-	-
Total Liabilities	1.89M	1.6M	2.09M	4.08M	3.82M
Common Stock, Total	7M	7M	7M	7M	7M
Additional Paid In Capital	809K	809K	809K	809K	809K
Retained Earnings	-6.51M	-7.17M	-9.4M	-10.34M	-10.84M
Comprehensive Income and Other	487K	453K	449K	501K	461K
Total Common Equity	1.79M	1.09M	-1.14M	-2.03M	-2.57M
Total Equity	1.79M	1.09M	-1.14M	-2.03M	-2.57M
Total Liabilities And Equity	3.68M	2.69M	952K	2.05M	1.24M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	54M	54M	54M	54M	54M
ECS Total Common Shares Outstanding	54M	54M	54M	54M	54M
Book Value / Share	0.03	0.02	-0.02	-0.04	-0.05
Tangible Book Value	30.88K	-588K	-1.4M	-2.65M	-3.11M
Tangible Book Value Per Share	0	-0.01	-0.03	-0.05	-0.06
Total Debt	262K	702K	1.6M	3.07M	3.44M
Net Debt	104K	568K	1.55M	2.83M	3.4M
Debt Equivalent Oper. Leases	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Finished Goods, Total	330K	61.52K	633	261K	306K
Machinery, Total	-	-	-	10.07K	9.59K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	-797K	-664K	-2.22M	-947K	-499K
Depreciation & Amortization - CF	-	-	-	8.1K	28.69K
Amortization of Goodwill and Intangible Assets - (CF)	28.17K	108K	322K	15.93K	54.62K
Depreciation & Amortization, Total	28.17K	108K	322K	24.03K	83.3K
Asset Writedown & Restructuring Costs	15.62K	-	943K	-	-
Stock-Based Compensation (CF)	261	-	-	-	-
Provision and Write-off of Bad Debts	1.32K	-	-	-	-
Other Operating Activities, Total	42.97K	-191K	90.35K	150K	90.2K
Change In Accounts Receivable	-246K	275K	55.2K	-75.45K	5.63K
Change In Inventories	-64.51K	293K	60.89K	-28.85K	-44.79K
Change In Accounts Payable	226K	-28.87K	-249K	266K	-234K
Change in Other Net Operating Assets	-5.89K	-28.86K	-18.92K	201K	-12.5K
Cash from Operations	-799K	-237K	-1.02M	-410K	-611K
Cash Acquisitions	-	-	-	-612K	-219K
Sale (Purchase) of Intangible assets	-	-	-	-	265K
Other Investing Activities, Total	-	-227K	-	-	-
Cash from Investing	-	-227K	-	-612K	45.4K
Short Term Debt Issued, Total	222K	439K	940K	1.21M	410K
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	222K	439K	940K	1.21M	410K
Long-Term Debt Repaid, Total	-	-	-	-9.88K	-32.89K
Total Debt Repaid	-	-	-	-9.88K	-32.89K
Other Financing Activities, Total	-	-	-	-	-
Cash from Financing	222K	439K	940K	1.2M	377K
Foreign Exchange Rate Adjustments	24.04K	-	-	6.21K	-2.05K
Net Change in Cash	-552K	-24.32K	-80.78K	183K	-191K
Supplemental Items
Cash Income Tax Paid (Refund)	-	-	-	-	4.15K
Levered Free Cash Flow	-558K	-437K	-800K	-222K	-505K
Unlevered Free Cash Flow	-556K	-426K	-752K	-121K	-393K
Change In Net Working Capital	93.04K	-51.14K	273K	-394K	522K
Net Debt Issued / Repaid	222K	439K	940K	1.2M	377K

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	-13.71	-18.37	-44.06	-35.94	-13.27
Return on Total Capital	-23.79	-30.44	-71.01	-71.82	-22.88
Return On Equity %	-41.57	-46.11	9.74K	59.78	21.69
Return on Common Equity	-41.57	-46.11	9.74K	59.78	21.69
Margin Analysis
Gross Profit Margin %	12.7	22.76	19.36	45.03	38.06
SG&A Margin	54.52	91.29	273.74	137.23	62.95
EBITDA Margin %	-43.28	-66.44	-233.18	-177.78	-21.6
EBITA Margin %	-43.28	-66.44	-233.18	-177.97	-21.84
EBIT Margin %	-44.89	-75.08	-311.3	-181.32	-25.88
Income From Continuing Operations Margin %	-45.44	-53.26	-539.7	-199.23	-36.99
Net Income Margin %	-45.44	-53.26	-539.7	-199.23	-36.99
Net Avail. For Common Margin %	-45.44	-53.26	-539.7	-199.23	-36.99
Normalized Net Income Margin	-28.4	-33.29	-194.35	-124.52	-23.04
Levered Free Cash Flow Margin	-31.85	-35.02	-194.21	-46.78	-37.41
Unlevered Free Cash Flow Margin	-31.74	-34.18	-182.59	-25.41	-29.11
Asset Turnover
Asset Turnover	0.49	0.39	0.23	0.32	0.82
Fixed Assets Turnover	-	-	-	-	5.55
Receivables Turnover (Average Receivables)	4.03	4.05	2.53	5.05	31.49
Inventory Turnover (Average Inventory)	5.14	4.92	10.69	1.99	2.94
Short Term Liquidity
Current Ratio	0.76	0.4	0.2	0.19	0.12
Quick Ratio	0.45	0.2	0.09	0.12	0.02
Operating Cash Flow to Current Liabilities	-0.42	-0.15	-0.49	-0.11	-0.17
Days Sales Outstanding (Average Receivables)	90.6	90.07	144.51	72.52	11.59
Days Outstanding Inventory (Average Inventory)	71.07	74.23	34.14	183.55	123.96
Average Days Payable Outstanding	213.38	449.49	787.43	495.33	276.08
Cash Conversion Cycle (Average Days)	-51.72	-285.18	-608.78	-239.26	-140.53
Long Term Solvency
Total Debt/Equity	14.66	64.31	-140.94	-150.94	-133.99
Total Debt / Total Capital	12.79	39.14	344.29	296.31	394.23
LT Debt/Equity	-	-	-	-10.78	-6.96
Long-Term Debt / Total Capital	-	-	-	21.15	20.47
Total Liabilities / Total Assets	51.43	59.4	219.37	199.3	306.59
EBIT / Interest Expense	-259.08	-56.27	-16.74	-5.3	-1.95
EBITDA / Interest Expense	-249.81	-49.79	-12.54	-5.16	-1.48
(EBITDA - Capex) / Interest Expense	-249.81	-49.79	-12.54	-5.16	-1.48
Total Debt / EBITDA	-0.35	-0.85	-1.67	-3.66	-12.95
Net Debt / EBITDA	-0.14	-0.69	-1.61	-3.38	-12.78
Total Debt / (EBITDA - Capex)	-0.35	-0.85	-1.67	-3.66	-12.95
Net Debt / (EBITDA - Capex)	-0.14	-0.69	-1.61	-3.38	-12.78
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	27.47	-28.87	-66.95	15.36	183.9
Gross Profit, 1 Yr. Growth %	22.54	27.45	-71.88	168.22	139.99
EBITDA, 1 Yr. Growth %	8.16	9.2	16	-12.05	-65.51
EBITA, 1 Yr. Growth %	8.16	9.2	16	-11.96	-65.16
EBIT, 1 Yr. Growth %	10.88	18.98	37.03	-32.81	-59.47
Earnings From Cont. Operations, 1 Yr. Growth %	12.86	-16.63	234.91	-57.42	-47.29
Net Income, 1 Yr. Growth %	12.86	-16.63	234.91	-57.42	-47.29
Normalized Net Income, 1 Yr. Growth %	12.86	-16.63	92.96	-26.09	-47.46
Diluted EPS Before Extra, 1 Yr. Growth %	12.86	-16.63	234.93	-57.42	-47.29
Accounts Receivable, 1 Yr. Growth %	-4.81	-54.99	-29.15	-60.79	-38.46
Inventory, 1 Yr. Growth %	24.28	-81.37	-98.97	41.21K	17.13
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	-	-15.42
Total Assets, 1 Yr. Growth %	5.5	-27.05	-64.56	114.83	-39.18
Tangible Book Value, 1 Yr. Growth %	-86.73	-2K	138.18	133.39	17.19
Common Equity, 1 Yr. Growth %	-12.42	-39.02	-204.18	78.72	26.54
Cash From Operations, 1 Yr. Growth %	120.84	-70.32	330.74	-59.83	48.96
Levered Free Cash Flow, 1 Yr. Growth %	11.52	-21.79	83.3	-72.22	127.06
Unlevered Free Cash Flow, 1 Yr. Growth %	11.14	-23.39	76.53	-83.95	225.31
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.07	-4.78	-51.51	-38.25	80.97
Gross Profit, 2 Yr. CAGR %	113.31	24.97	-40.13	-13.15	153.71
EBITDA, 2 Yr. CAGR %	-	8.68	12.54	1	-44.93
EBITA, 2 Yr. CAGR %	-26.74	8.68	12.54	1.06	-44.62
EBIT, 2 Yr. CAGR %	-25.39	14.86	27.69	-4.04	-47.82
Earnings From Cont. Operations, 2 Yr. CAGR %	-19.03	-3	67.1	19.42	-52.62
Net Income, 2 Yr. CAGR %	-19.03	-3	67.1	19.42	-52.62
Normalized Net Income, 2 Yr. CAGR %	-19.03	-3	26.84	19.42	-37.69
Diluted EPS Before Extra, 2 Yr. CAGR %	-19.02	-3	67.1	19.42	-52.62
Accounts Receivable, 2 Yr. CAGR %	-20.34	-34.55	-43.53	-47.29	-50.88
Inventory, 2 Yr. CAGR %	93.98	-51.88	-95.62	106.16	2.1K
Total Assets, 2 Yr. CAGR %	-8.43	-12.27	-49.16	-12.75	14.31
Tangible Book Value, 2 Yr. CAGR %	-82.34	58.98	573.58	112.36	65.38
Common Equity, 2 Yr. CAGR %	-20.7	-26.92	-20.29	36.45	50.38
Cash From Operations, 2 Yr. CAGR %	-24.81	-19.04	13.06	31.54	-22.64
Levered Free Cash Flow, 2 Yr. CAGR %	-29.73	-6.61	19.73	-28.64	-20.58
Unlevered Free Cash Flow, 2 Yr. CAGR %	-29.85	-7.73	16.29	-46.77	-27.74
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	98.71	2.52	-33.08	-35.27	2.68
Gross Profit, 3 Yr. CAGR %	89.43	79.66	-23.99	-1.31	21.87
EBITDA, 3 Yr. CAGR %	-	-	11.06	3.66	-29.4
EBITA, 3 Yr. CAGR %	-20.05	-16.32	11.06	3.7	-29.14
EBIT, 3 Yr. CAGR %	-19.08	-12.84	21.82	3.09	-28
Earnings From Cont. Operations, 3 Yr. CAGR %	-17.54	-18.23	46.61	5.94	-9.07
Net Income, 3 Yr. CAGR %	-17.54	-18.23	46.61	5.94	-9.07
Normalized Net Income, 3 Yr. CAGR %	-17.54	-18.23	22	5.94	-9.17
Diluted EPS Before Extra, 3 Yr. CAGR %	-17.54	-18.23	46.61	5.94	-9.07
Accounts Receivable, 3 Yr. CAGR %	15.74	-34.14	-32.79	-50	-44.5
Inventory, 3 Yr. CAGR %	123.69	-11.16	-86.64	-7.48	70.75
Total Assets, 3 Yr. CAGR %	-11.06	-15.12	-35.15	-17.8	-22.64
Tangible Book Value, 3 Yr. CAGR %	-75.35	-15.95	81.91	341.24	74.18
Common Equity, 3 Yr. CAGR %	-23.35	-27.35	-17.75	4.33	33.07
Cash From Operations, 3 Yr. CAGR %	-18.07	-44.84	41.33	-19.92	37.11
Levered Free Cash Flow, 3 Yr. CAGR %	10.84	-27.18	16.93	-26.42	4.96
Unlevered Free Cash Flow, 3 Yr. CAGR %	10.72	-27.76	14.55	-39.9	-2.68
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	13.03	-16.3	-0.37
Gross Profit, 5 Yr. CAGR %	-	-	19.49	34.33	23.1
EBITDA, 5 Yr. CAGR %	-	-	-	-	-16.11
EBITA, 5 Yr. CAGR %	271.1	35.09	-8.33	-9.76	-15.92
EBIT, 5 Yr. CAGR %	273.81	38.43	-2.88	-9.42	-13.21
Earnings From Cont. Operations, 5 Yr. CAGR %	274.73	-22.38	9.38	-4.86	-6.69
Net Income, 5 Yr. CAGR %	274.73	-22.38	9.38	-4.86	-6.69
Normalized Net Income, 5 Yr. CAGR %	274.7	29.23	-2.04	-4.86	-6.75
Diluted EPS Before Extra, 5 Yr. CAGR %	255.44	-25.96	9.38	-4.86	-6.69
Accounts Receivable, 5 Yr. CAGR %	-	-	-13.14	-39.76	-40.71
Inventory, 5 Yr. CAGR %	-	-	-53.62	24.4	2.88
Total Assets, 5 Yr. CAGR %	718.96	-16.59	-28.89	-14.18	-18.65
Tangible Book Value, 5 Yr. CAGR %	21.58	-29.17	-7.44	21.77	67.94
Common Equity, 5 Yr. CAGR %	173.82	-26.41	-22.14	-6.52	4.7
Cash From Operations, 5 Yr. CAGR %	-	16.88	-6.8	-21.91	11.06
Levered Free Cash Flow, 5 Yr. CAGR %	324.71	-4.01	14.32	-27.76	0.17
Unlevered Free Cash Flow, 5 Yr. CAGR %	324.42	-4.48	12.91	-36.07	-4.73